Back to Journals » Lung Cancer: Targets and Therapy
Lung Cancer: Targets and Therapy
Editor-in-Chief: Professor Sai-Hong Ignatius Ou
An international, peer-reviewed, open access journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (215)
- Volume 17, 2026 (7)
- Volume 16, 2025 (17)
- Volume 15, 2024 (19)
- Volume 14, 2023 (12)
- Volume 13, 2022 (8)
- Volume 12, 2021 (14)
- Volume 11, 2020 (11)
- Volume 10, 2019 (16)
- Volume 9, 2018 (14)
- Volume 8, 2017 (25)
- Volume 7, 2016 (17)
- Volume 6, 2015 (9)
- Volume 5, 2014 (10)
- Volume 4, 2013 (9)
- Volume 3, 2012 (9)
- Volume 2, 2011 (6)
- Volume 1, 2010 (12)
Latest articles:
- 5 records -
Sunvozertinib in EGFR Exon 20 Insertion NSCLC: Approved but Not Available – Practical Dose Selection Considerations and Real-World Access Challenges
Aldecoa KAT, Arter ZL, Ou SHI, Nagasaka M
Lung Cancer: Targets and Therapy 2026, 17:592922
Published Date: 28 May 2026
Response to Selpercatinib in a CCDC6-RET Lung Adenocarcinoma with an Acquired Novel RET p.L730_G731insL After Progression on Pralsetinib: A Case Report
Tian C, Zou Y, Liu J, Zhao J, Tian S, Liu Y, Wang G
Lung Cancer: Targets and Therapy 2026, 17:605845
Published Date: 20 May 2026
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib – A Case Report
Nagasaka M, Arter ZL, Park CJ, Sarkari A, Ou SI
Lung Cancer: Targets and Therapy 2026, 17:600499
Published Date: 14 May 2026
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer
Liu SYM, Xie Z, Yan L, Jie GL, Deng JY, Zhang Q, Huang Z, Wang J, Zhang Z, Shao Y, Meng H, Zhang Y, Zhang XC, Chen HJ, Zhong WZ, Zhou Q, Wu YL
Lung Cancer: Targets and Therapy 2026, 17:596080
Published Date: 8 May 2026
Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients
Lumjiaktase P, Kemawichanurat N, Santiwiwas K, Kuttiyod T, Oranratnachai S, Trachu N, Monnamo N, Khiewngam K, Simmalee K, Reungwetwattana T
Lung Cancer: Targets and Therapy 2026, 17:578622
Published Date: 16 March 2026